| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.34T | 1.30T | 1.15T | 952.69B | 810.54B |
| Gross Profit | 243.17B | 206.92B | 218.36B | 184.57B | 155.32B |
| EBITDA | 154.55B | 141.41B | 142.78B | 126.11B | 106.46B |
| Net Income | 100.67B | 92.92B | 92.05B | 77.88B | 69.58B |
Balance Sheet | |||||
| Total Assets | 1.41T | 1.28T | 1.20T | 1.03T | 879.91B |
| Cash, Cash Equivalents and Short-Term Investments | 421.90B | 409.96B | 401.88B | 349.31B | 337.73B |
| Total Debt | 720.06B | 611.77B | 575.14B | 508.96B | 437.18B |
| Total Liabilities | 873.16B | 746.17B | 718.25B | 635.47B | 532.77B |
| Stockholders Equity | 538.63B | 464.72B | 416.60B | 338.09B | 294.36B |
Cash Flow | |||||
| Free Cash Flow | 26.42B | 99.92B | 11.01B | -19.50B | 48.34B |
| Operating Cash Flow | 29.53B | 104.76B | 17.39B | -16.36B | 50.12B |
| Investing Cash Flow | -11.11B | -22.06B | -35.01B | -4.88B | 23.54B |
| Financing Cash Flow | -2.96B | -69.78B | 48.54B | 25.21B | 40.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥986.54B | 25.41 | 11.06% | 2.88% | 11.00% | 88.70% | |
78 Outperform | ¥4.75T | 18.13 | 10.15% | 1.86% | 18.31% | 71.89% | |
74 Outperform | ¥1.23T | 9.43 | 19.43% | 5.16% | 5.16% | 6.00% | |
72 Outperform | ¥1.15T | 9.44 | 19.60% | 1.94% | 3.13% | 11.87% | |
71 Outperform | ¥5.49T | 11.76 | 7.67% | 1.18% | 7.97% | 13.59% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥164.98B | 20.44 | 8.95% | 3.39% | 28.94% | 109.35% |